PL2451964T3 - Kompozycje kondycjonowanego podłoża i macierzy zewnątrzkomórkowej z komórek hodowanych w warunkach hipoksji - Google Patents

Kompozycje kondycjonowanego podłoża i macierzy zewnątrzkomórkowej z komórek hodowanych w warunkach hipoksji

Info

Publication number
PL2451964T3
PL2451964T3 PL10797941T PL10797941T PL2451964T3 PL 2451964 T3 PL2451964 T3 PL 2451964T3 PL 10797941 T PL10797941 T PL 10797941T PL 10797941 T PL10797941 T PL 10797941T PL 2451964 T3 PL2451964 T3 PL 2451964T3
Authority
PL
Poland
Prior art keywords
extracellular matrix
conditioned medium
cells cultured
cultured under
hypoxic conditions
Prior art date
Application number
PL10797941T
Other languages
English (en)
Inventor
Gail K. Naughton
Frank Zeigler
Mark Baumgartner
Kyle Nickey
Original Assignee
Histogen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/501,312 external-priority patent/US20100166824A1/en
Priority claimed from US12/509,171 external-priority patent/US8530415B2/en
Priority claimed from US12/547,422 external-priority patent/US8524494B2/en
Priority claimed from US12/632,721 external-priority patent/US8535913B2/en
Application filed by Histogen, Inc. filed Critical Histogen, Inc.
Publication of PL2451964T3 publication Critical patent/PL2451964T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/02—Tissue, human, animal or plant cell, or virus culture apparatus with means providing suspensions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Sustainable Development (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL10797941T 2009-07-10 2010-07-09 Kompozycje kondycjonowanego podłoża i macierzy zewnątrzkomórkowej z komórek hodowanych w warunkach hipoksji PL2451964T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US12/501,312 US20100166824A1 (en) 2008-01-30 2009-07-10 Extracellular matrix compositions
US12/509,171 US8530415B2 (en) 2008-01-30 2009-07-24 Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions
US12/547,422 US8524494B2 (en) 2008-01-30 2009-08-25 Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro
US12/632,721 US8535913B2 (en) 2008-01-30 2009-12-07 Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells
EP10797941.1A EP2451964B1 (en) 2009-07-10 2010-07-09 Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions
PCT/US2010/041583 WO2011006107A1 (en) 2009-07-10 2010-07-09 Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions

Publications (1)

Publication Number Publication Date
PL2451964T3 true PL2451964T3 (pl) 2018-08-31

Family

ID=43429571

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10797941T PL2451964T3 (pl) 2009-07-10 2010-07-09 Kompozycje kondycjonowanego podłoża i macierzy zewnątrzkomórkowej z komórek hodowanych w warunkach hipoksji

Country Status (16)

Country Link
EP (1) EP2451964B1 (pl)
KR (1) KR101834019B1 (pl)
CN (1) CN102482698B (pl)
AU (1) AU2010271212B2 (pl)
BR (1) BR112012000517B1 (pl)
CA (2) CA2767600C (pl)
DK (1) DK2451964T3 (pl)
ES (1) ES2667265T3 (pl)
HR (1) HRP20180594T1 (pl)
HU (1) HUE038882T2 (pl)
MX (1) MX2012000455A (pl)
NO (1) NO2451964T3 (pl)
PL (1) PL2451964T3 (pl)
PT (1) PT2451964T (pl)
RU (1) RU2631488C2 (pl)
WO (1) WO2011006107A1 (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103387959A (zh) * 2012-10-19 2013-11-13 夏佑红 一种乳牙干细胞及其制备方法和应用
CA3106271A1 (en) * 2013-01-25 2014-07-31 Xcell Biosciences, Inc. Methods, compositions, kits, and systems for selective enrichment of target cells
US10533191B2 (en) 2014-01-15 2020-01-14 Serucell Corporation Therapeutic serum obtained from co-cultured cells
WO2017186273A1 (en) * 2016-04-26 2017-11-02 Isletone Ab Derivation and self-renewal of multipotent cells and uses thereof
FR3055806B1 (fr) * 2016-09-15 2024-04-12 Symbioken Procede de preparation d’une composition pour la reparation tissulaire
KR101885373B1 (ko) 2016-10-20 2018-08-03 한남대학교 산학협력단 간헐적 저산소에 노출된 쥐 간의 유전자 분석방법
CN106511384A (zh) * 2016-11-08 2017-03-22 广州医科大学附属第三医院 一种用于促进糖尿病创面愈合的冻干粉及其制备方法
KR102009081B1 (ko) * 2016-12-23 2019-08-09 주식회사 인스코비 발모 촉진을 위한 생체 식립용 임플란트
JP6557717B2 (ja) 2016-12-23 2019-08-07 インスコビー・インコーポレイテッドＩｎｓｃｏｂｅｅ，Ｉｎｃ． 生体植立用インプラント及びその製造方法
AU2018368440B2 (en) 2017-11-16 2022-03-03 Aivita Biomedical, Inc. Use of cell membrane-bound signaling factors
WO2019140267A1 (en) * 2018-01-12 2019-07-18 Histogen, Inc. Nutraceutical products from cell conditioned medium from cells cultured under hypoxic conditions
US20210038652A1 (en) * 2018-01-30 2021-02-11 Histogen, Inc. Extracellular vesicles derived from cells cultured under hypoxic conditions and uses thereof
KR102454189B1 (ko) * 2018-05-04 2022-10-14 연세대학교 산학협력단 저산소 조건을 이용한 모유두 세포 및 세포 스페로이드의 제조방법
CA3107592A1 (en) * 2018-08-02 2020-02-06 Histogen, Inc. Conditioned medium and extracellular matrix compositions and uses thereof
KR20200040536A (ko) * 2018-10-10 2020-04-20 사회복지법인 삼성생명공익재단 저산소 조건에서 섬유아세포를 배양하여 제조한 조정배지를 포함하는 암세포 사멸 유도용 조성물 및 이의 제조 방법
KR102135178B1 (ko) 2019-01-15 2020-07-17 한남대학교 산학협력단 고중력에 노출된 쥐의 유전자 분석방법
US11352258B2 (en) 2019-03-04 2022-06-07 Honda Motor Co., Ltd. Multifunctional conductive wire and method of making
US20200316255A1 (en) * 2019-04-03 2020-10-08 The Secant Group, Llc Human cell-deposited extracellular matrix coatings for textiles and fibers
US10881693B2 (en) 2019-04-09 2021-01-05 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
CN114126717A (zh) * 2019-04-30 2022-03-01 艾克斯赛尔生物科学公司 用于调整细胞表型的系统和方法
CN114450016B (zh) * 2019-09-26 2024-09-17 智再如股份有限公司 生物组织损伤修复剂的制造方法及生物组织损伤修复剂
KR102166453B1 (ko) 2020-02-03 2020-10-15 중앙대학교 산학협력단 Hapln1을 포함하는 폐질환 예방 또는 치료용 조성물
US12077780B2 (en) * 2020-02-14 2024-09-03 Allergan Sales, Llc Conditioned medium from cells cultured under hypoxic conditions and uses thereof
KR20230035517A (ko) 2020-04-07 2023-03-14 컴반지오, 인크. 동결건조 중간엽 줄기세포 유래 세크레톰 및 이의 용도
CA3176245A1 (en) * 2020-09-14 2022-03-17 Ginkgo Bioworks, Inc. Use of bone morphogenetic proteins and their receptors for aesthetics and cosmetics
KR102406953B1 (ko) * 2021-05-17 2022-06-10 주식회사 에피바이오텍 신규한 모유두 세포 분리 방법
CN115518198B (zh) * 2022-10-11 2024-01-16 青岛大学 一种负载双向梯度ecm涂层的血管修复支架及其制备方法
KR102823859B1 (ko) 2022-10-24 2025-06-23 인하대학교 산학협력단 세포 배양 배지 내 산소 농도 조절 방법 및 이를 위한 장치
CN121002174A (zh) * 2023-04-03 2025-11-21 艾奇埃尔璧细胞株式会社 包含细胞外基质及基质结合囊泡的用于制备细胞外基质的组合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX163953B (es) * 1984-03-27 1992-07-03 Univ New Jersey Med Procedimiento para preparar una matriz biodegradable a base de colageno
US7410773B2 (en) * 1995-02-02 2008-08-12 Ghazi Jaswinder Dhoot Method of preparing an undifferentiated cell
US5830708A (en) 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
US6610540B1 (en) * 1998-11-18 2003-08-26 California Institute Of Technology Low oxygen culturing of central nervous system progenitor cells
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6280284B1 (en) 2000-03-17 2001-08-28 Carl Winefordner Toy submarine with counter rotating propellers
US20020155440A1 (en) * 2000-12-19 2002-10-24 Ljubimova Julia Y. Using overexpression of laminin alpha 4 subunit as a diagnostic and prognostic indicator of malignant tumors
AU2002247044B2 (en) 2001-01-30 2006-11-16 Orthogene, Inc. Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells
ITPD20010032A1 (it) * 2001-02-09 2002-08-09 Fidia Advanced Biopolymers Srl Innesti ingegnerizzati per la riparazione di difetti osteocondrali
US20050032208A1 (en) * 2003-06-18 2005-02-10 Oh Steve Kah Weng Materials and methods to produce stem cells
ES2297516T3 (es) 2003-12-02 2008-05-01 Universiteit Gent Uso de alginato polisulfatado en matrices celulares.
WO2005104766A2 (en) * 2004-04-28 2005-11-10 Myocardial Therapeutics, Inc. Injection of bone marrow-derived conditioned medium for angiogenesis
US7828711B2 (en) * 2004-08-16 2010-11-09 Cardiac Pacemakers, Inc. Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
US20060154365A1 (en) * 2004-08-30 2006-07-13 Anthony Ratcliffe Cultured three dimensional tissues and uses thereof
EP2322600B1 (en) * 2004-08-30 2012-03-21 Theregen, Inc. Cultured three dimensional tissues and uses thereof
CA2714387C (en) * 2008-01-30 2018-06-19 Histogen, Inc. Extracellular matrix compositions

Also Published As

Publication number Publication date
BR112012000517A2 (pt) 2021-01-05
CA2767600C (en) 2022-05-31
CN102482698B (zh) 2018-09-25
EP2451964B1 (en) 2018-01-24
CN102482698A (zh) 2012-05-30
CA2767600A1 (en) 2011-01-13
AU2010271212B2 (en) 2015-07-16
KR101834019B1 (ko) 2018-03-02
MX2012000455A (es) 2012-04-11
DK2451964T3 (en) 2018-04-30
NO2451964T3 (pl) 2018-06-23
RU2631488C2 (ru) 2017-09-22
BR112012000517B1 (pt) 2022-04-12
PT2451964T (pt) 2018-05-07
HRP20180594T1 (hr) 2018-08-10
EP2451964A4 (en) 2013-04-17
ES2667265T3 (es) 2018-05-10
CA3152419A1 (en) 2011-01-13
RU2012104650A (ru) 2013-08-20
KR20120089235A (ko) 2012-08-09
EP2451964A1 (en) 2012-05-16
AU2010271212A1 (en) 2012-03-01
WO2011006107A1 (en) 2011-01-13
HUE038882T2 (hu) 2018-12-28

Similar Documents

Publication Publication Date Title
PL2451964T3 (pl) Kompozycje kondycjonowanego podłoża i macierzy zewnątrzkomórkowej z komórek hodowanych w warunkach hipoksji
IL214798A0 (en) Methods and compositions for stem cell cultures
EP2391711A4 (en) NEW CELL LINES AND METHOD
IL226971B (en) Cell culture medium
IL222452A0 (en) Improved cell culture medium
EP2346358A4 (en) EXTRACT OF ON THE BASIS OF REGENERATIVE CELLS CULTURED CONDITIONED MEDIUM
EP2155859A4 (en) FORMULATIONS AND METHODS FOR CULTIVATING EMBRYONIC STEM CELLS
ZA201105749B (en) Variant axmi-r1 delta-endotoxin genes and methods for their use
IL228818A0 (en) Stem cell cultures
EP2297326A4 (en) VCP-BASED VECTORS FOR THE TRANSFORMATION OF ALGAE CELLS
SG10201503304RA (en) Cell culture processes
IL222453A0 (en) Improved cell culture medium
EP2401696A4 (en) MAMMALIAN CELL LINE MODELS AND RELATED METHODS
IL211368A0 (en) Compositions and methods for regulating cell osmolarity
GB0914195D0 (en) Vessel for culturing cells
EP2448957A4 (en) METHODS AND COMPOSITIONS FOR AFFECTING CLOSTRIDIA DIFFERENTIATION IN CULTURE
GB0800524D0 (en) Cell culture system
PT2233560T (pt) Dispositivo de cultura de células ou tecidos e conjunto associado
GB0817990D0 (en) Cell culture vessel
EP2294182A4 (en) CULTS OF MULTIPOTENT STEM CELLS
GB0817240D0 (en) Modified bacterial cell
PL2480655T3 (pl) Podłoże do hodowli komórkowych
SG10201504220YA (en) Method for inducing pluripotency in human somatic cells with prdm14 or nfrkb
EP2185685A4 (en) NEW PROCESSES AND NEW CELL LINES
GB0922428D0 (en) Cell culture